Novavax (Germany) Today
| NVV1 Stock | EUR 8.31 0.26 3.03% |
Performance0 of 100
| Odds Of DistressOver 62
|
Novavax is trading at 8.31 as of the 11th of December 2024. This is a 3.03 percent decrease since the beginning of the trading day. The stock's lowest day price was 8.31. Novavax has more than 62 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2023 and ending today, the 11th of December 2024. Click here to learn more.
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. The company has 85 M outstanding shares. More on Novavax
Moving together with Novavax Stock
| 0.7 | NOVA | Novo Nordisk AS | PairCorr |
| 0.62 | CSJA | CSL LTD SPONADR | PairCorr |
| 0.65 | CSJ | CSL Limited | PairCorr |
| 0.74 | MBG | Mercedes Benz Group | PairCorr |
| 0.85 | 0QF | Moderna | PairCorr |
Moving against Novavax Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Novavax Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Novavax's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Novavax or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Stanley Erck |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Novavax (NVV1) is traded on Frankfurt Exchange in Germany and employs 1,541 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 727.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novavax's market, we take the total number of its shares issued and multiply it by Novavax's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Novavax operates under Healthcare sector and is part of Biotechnology industry. The entity has 85 M outstanding shares.
Novavax has accumulated about 1.57 B in cash with 322.95 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Novavax Probability Of Bankruptcy
Ownership AllocationNovavax maintains a total of 85 Million outstanding shares. Over half of Novavax's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Novavax. Please watch out for any change in the institutional holdings of Novavax as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Novavax Ownership Details
Novavax Risk Profiles
Although Novavax's alpha and beta are two of the key measurements used to evaluate Novavax's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.84 | |||
| Standard Deviation | 5.69 | |||
| Variance | 32.38 | |||
| Risk Adjusted Performance | (0.02) |
Novavax Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Novavax without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Novavax Corporate Management
Elected by the shareholders, the Novavax's board of directors comprises two types of representatives: Novavax inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novavax. The board's role is to monitor Novavax's management team and ensure that shareholders' interests are well served. Novavax's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novavax's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS | Exec Officer | Profile | |
| Jody Lichaa | Senior Vice President - Quality Assurance | Profile | |
| Ben Machielse | Executive Vice President - CMC | Profile | |
| Michael McManus | Independent Director | Profile | |
| Brian Webb | Senior Vice President - Manufacturing | Profile |
Additional Information and Resources on Investing in Novavax Stock
When determining whether Novavax offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novavax's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novavax Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novavax Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Novavax Stock please use our How to Invest in Novavax guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.